Bausch Health Reports Strong Q4 Earnings, Projects 10% Revenue Growth

Bausch Health Companies Inc. reported strong financial results for 2024, with revenues reaching $9.625 billion, a 10% increase from 2023, and an operating income of $1.546 billion, improved significantly from the previous year. The fourth-quarter earnings report also exceeded expectations, with revenue of $2.56 billion surpassing estimates, and adjusted earnings per share of $1.21 beating the consensus by 8.04%. Notably, the Solta segment, focusing on medical aesthetics, experienced a remarkable 34% revenue growth, driven primarily by demand in South Korea and China. The company anticipates continued growth, projecting 2025 revenues between $9.90 billion and $10.15 billion. Despite the positive results, BHC shares have underperformed in the market, remaining about 35% below analysts' average target price. CEO Thomas Appio emphasized 2024 as a year dedicated to fulfilling commitments and maintaining strong operational performance.